Pharma & Healthcare
Global Human-mouse Chimeric Antibody Market Research Report 2025
- Jun 25, 25
- ID: 334929
- Pages: 99
- Figures: 94
- Views: 3
The global market for Human-mouse Chimeric Antibody was valued at US$ 21452 million in the year 2024 and is projected to reach a revised size of US$ 28363 million by 2031, growing at a CAGR of 4.2% during the forecast period.
A human-mouse chimeric antibody is a type of monoclonal antibody engineered by combining the variable regions of a mouse antibody (which determines antigen specificity) with the constant regions of a human antibody. This design reduces immunogenicity in humans compared to fully murine antibodies, while retaining the mouse antibody’s ability to bind its target. Chimeric antibodies are typically around 65–70% human and are used in the treatment of cancers, autoimmune diseases, and transplant rejection.
North American market for Human-mouse Chimeric Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human-mouse Chimeric Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Human-mouse Chimeric Antibody in Cancers is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Human-mouse Chimeric Antibody include Roche AG, Johnson & Johnson, Celltrion, Pfizer, Merck KGaA, Sanofi, Teva, Eli Lilly & Co, Amgen, Merck & Co, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human-mouse Chimeric Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human-mouse Chimeric Antibody.
The Human-mouse Chimeric Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human-mouse Chimeric Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human-mouse Chimeric Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche AG
Johnson & Johnson
Celltrion
Pfizer
Merck KGaA
Sanofi
Teva
Eli Lilly & Co
Amgen
Merck & Co
Sandoz
Shanghai Henlius Biopharmaceutical
United Therapeutics
Innovent Bio
Mitsubishi Tanabe Pharma
Kyowa Kirin
Segment by Type
Infliximab
Rituximab
Emicizumab
Cetuximab
Esatuximab
Other
Segment by Application
Cancers
Autoimmune Diseases
Transplant Rejection
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human-mouse Chimeric Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A human-mouse chimeric antibody is a type of monoclonal antibody engineered by combining the variable regions of a mouse antibody (which determines antigen specificity) with the constant regions of a human antibody. This design reduces immunogenicity in humans compared to fully murine antibodies, while retaining the mouse antibody’s ability to bind its target. Chimeric antibodies are typically around 65–70% human and are used in the treatment of cancers, autoimmune diseases, and transplant rejection.
North American market for Human-mouse Chimeric Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human-mouse Chimeric Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Human-mouse Chimeric Antibody in Cancers is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Human-mouse Chimeric Antibody include Roche AG, Johnson & Johnson, Celltrion, Pfizer, Merck KGaA, Sanofi, Teva, Eli Lilly & Co, Amgen, Merck & Co, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human-mouse Chimeric Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human-mouse Chimeric Antibody.
The Human-mouse Chimeric Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human-mouse Chimeric Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human-mouse Chimeric Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche AG
Johnson & Johnson
Celltrion
Pfizer
Merck KGaA
Sanofi
Teva
Eli Lilly & Co
Amgen
Merck & Co
Sandoz
Shanghai Henlius Biopharmaceutical
United Therapeutics
Innovent Bio
Mitsubishi Tanabe Pharma
Kyowa Kirin
Segment by Type
Infliximab
Rituximab
Emicizumab
Cetuximab
Esatuximab
Other
Segment by Application
Cancers
Autoimmune Diseases
Transplant Rejection
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human-mouse Chimeric Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human-mouse Chimeric Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Emicizumab
1.2.5 Cetuximab
1.2.6 Esatuximab
1.2.7 Other
1.3 Market by Application
1.3.1 Global Human-mouse Chimeric Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancers
1.3.3 Autoimmune Diseases
1.3.4 Transplant Rejection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human-mouse Chimeric Antibody Market Perspective (2020-2031)
2.2 Global Human-mouse Chimeric Antibody Growth Trends by Region
2.2.1 Global Human-mouse Chimeric Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human-mouse Chimeric Antibody Historic Market Size by Region (2020-2025)
2.2.3 Human-mouse Chimeric Antibody Forecasted Market Size by Region (2026-2031)
2.3 Human-mouse Chimeric Antibody Market Dynamics
2.3.1 Human-mouse Chimeric Antibody Industry Trends
2.3.2 Human-mouse Chimeric Antibody Market Drivers
2.3.3 Human-mouse Chimeric Antibody Market Challenges
2.3.4 Human-mouse Chimeric Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human-mouse Chimeric Antibody Players by Revenue
3.1.1 Global Top Human-mouse Chimeric Antibody Players by Revenue (2020-2025)
3.1.2 Global Human-mouse Chimeric Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Top Human-mouse Chimeric Antibody Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human-mouse Chimeric Antibody Revenue
3.4 Global Human-mouse Chimeric Antibody Market Concentration Ratio
3.4.1 Global Human-mouse Chimeric Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human-mouse Chimeric Antibody Revenue in 2024
3.5 Global Key Players of Human-mouse Chimeric Antibody Head office and Area Served
3.6 Global Key Players of Human-mouse Chimeric Antibody, Product and Application
3.7 Global Key Players of Human-mouse Chimeric Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human-mouse Chimeric Antibody Breakdown Data by Type
4.1 Global Human-mouse Chimeric Antibody Historic Market Size by Type (2020-2025)
4.2 Global Human-mouse Chimeric Antibody Forecasted Market Size by Type (2026-2031)
5 Human-mouse Chimeric Antibody Breakdown Data by Application
5.1 Global Human-mouse Chimeric Antibody Historic Market Size by Application (2020-2025)
5.2 Global Human-mouse Chimeric Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human-mouse Chimeric Antibody Market Size (2020-2031)
6.2 North America Human-mouse Chimeric Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human-mouse Chimeric Antibody Market Size by Country (2020-2025)
6.4 North America Human-mouse Chimeric Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human-mouse Chimeric Antibody Market Size (2020-2031)
7.2 Europe Human-mouse Chimeric Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human-mouse Chimeric Antibody Market Size by Country (2020-2025)
7.4 Europe Human-mouse Chimeric Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Human-mouse Chimeric Antibody Market Size (2020-2031)
8.2 Asia-Pacific Human-mouse Chimeric Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human-mouse Chimeric Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Human-mouse Chimeric Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Human-mouse Chimeric Antibody Market Size (2020-2031)
9.2 Latin America Human-mouse Chimeric Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human-mouse Chimeric Antibody Market Size by Country (2020-2025)
9.4 Latin America Human-mouse Chimeric Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human-mouse Chimeric Antibody Market Size (2020-2031)
10.2 Middle East & Africa Human-mouse Chimeric Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human-mouse Chimeric Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Human-mouse Chimeric Antibody Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche AG
11.1.1 Roche AG Company Details
11.1.2 Roche AG Business Overview
11.1.3 Roche AG Human-mouse Chimeric Antibody Introduction
11.1.4 Roche AG Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.1.5 Roche AG Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Human-mouse Chimeric Antibody Introduction
11.2.4 Johnson & Johnson Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Celltrion
11.3.1 Celltrion Company Details
11.3.2 Celltrion Business Overview
11.3.3 Celltrion Human-mouse Chimeric Antibody Introduction
11.3.4 Celltrion Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.3.5 Celltrion Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Human-mouse Chimeric Antibody Introduction
11.4.4 Pfizer Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Details
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Human-mouse Chimeric Antibody Introduction
11.5.4 Merck KGaA Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.5.5 Merck KGaA Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Human-mouse Chimeric Antibody Introduction
11.6.4 Sanofi Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Human-mouse Chimeric Antibody Introduction
11.7.4 Teva Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.7.5 Teva Recent Development
11.8 Eli Lilly & Co
11.8.1 Eli Lilly & Co Company Details
11.8.2 Eli Lilly & Co Business Overview
11.8.3 Eli Lilly & Co Human-mouse Chimeric Antibody Introduction
11.8.4 Eli Lilly & Co Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.8.5 Eli Lilly & Co Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Human-mouse Chimeric Antibody Introduction
11.9.4 Amgen Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.9.5 Amgen Recent Development
11.10 Merck & Co
11.10.1 Merck & Co Company Details
11.10.2 Merck & Co Business Overview
11.10.3 Merck & Co Human-mouse Chimeric Antibody Introduction
11.10.4 Merck & Co Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.10.5 Merck & Co Recent Development
11.11 Sandoz
11.11.1 Sandoz Company Details
11.11.2 Sandoz Business Overview
11.11.3 Sandoz Human-mouse Chimeric Antibody Introduction
11.11.4 Sandoz Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.11.5 Sandoz Recent Development
11.12 Shanghai Henlius Biopharmaceutical
11.12.1 Shanghai Henlius Biopharmaceutical Company Details
11.12.2 Shanghai Henlius Biopharmaceutical Business Overview
11.12.3 Shanghai Henlius Biopharmaceutical Human-mouse Chimeric Antibody Introduction
11.12.4 Shanghai Henlius Biopharmaceutical Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.12.5 Shanghai Henlius Biopharmaceutical Recent Development
11.13 United Therapeutics
11.13.1 United Therapeutics Company Details
11.13.2 United Therapeutics Business Overview
11.13.3 United Therapeutics Human-mouse Chimeric Antibody Introduction
11.13.4 United Therapeutics Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.13.5 United Therapeutics Recent Development
11.14 Innovent Bio
11.14.1 Innovent Bio Company Details
11.14.2 Innovent Bio Business Overview
11.14.3 Innovent Bio Human-mouse Chimeric Antibody Introduction
11.14.4 Innovent Bio Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.14.5 Innovent Bio Recent Development
11.15 Mitsubishi Tanabe Pharma
11.15.1 Mitsubishi Tanabe Pharma Company Details
11.15.2 Mitsubishi Tanabe Pharma Business Overview
11.15.3 Mitsubishi Tanabe Pharma Human-mouse Chimeric Antibody Introduction
11.15.4 Mitsubishi Tanabe Pharma Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.15.5 Mitsubishi Tanabe Pharma Recent Development
11.16 Kyowa Kirin
11.16.1 Kyowa Kirin Company Details
11.16.2 Kyowa Kirin Business Overview
11.16.3 Kyowa Kirin Human-mouse Chimeric Antibody Introduction
11.16.4 Kyowa Kirin Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.16.5 Kyowa Kirin Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human-mouse Chimeric Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Emicizumab
1.2.5 Cetuximab
1.2.6 Esatuximab
1.2.7 Other
1.3 Market by Application
1.3.1 Global Human-mouse Chimeric Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancers
1.3.3 Autoimmune Diseases
1.3.4 Transplant Rejection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human-mouse Chimeric Antibody Market Perspective (2020-2031)
2.2 Global Human-mouse Chimeric Antibody Growth Trends by Region
2.2.1 Global Human-mouse Chimeric Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human-mouse Chimeric Antibody Historic Market Size by Region (2020-2025)
2.2.3 Human-mouse Chimeric Antibody Forecasted Market Size by Region (2026-2031)
2.3 Human-mouse Chimeric Antibody Market Dynamics
2.3.1 Human-mouse Chimeric Antibody Industry Trends
2.3.2 Human-mouse Chimeric Antibody Market Drivers
2.3.3 Human-mouse Chimeric Antibody Market Challenges
2.3.4 Human-mouse Chimeric Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human-mouse Chimeric Antibody Players by Revenue
3.1.1 Global Top Human-mouse Chimeric Antibody Players by Revenue (2020-2025)
3.1.2 Global Human-mouse Chimeric Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Top Human-mouse Chimeric Antibody Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human-mouse Chimeric Antibody Revenue
3.4 Global Human-mouse Chimeric Antibody Market Concentration Ratio
3.4.1 Global Human-mouse Chimeric Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human-mouse Chimeric Antibody Revenue in 2024
3.5 Global Key Players of Human-mouse Chimeric Antibody Head office and Area Served
3.6 Global Key Players of Human-mouse Chimeric Antibody, Product and Application
3.7 Global Key Players of Human-mouse Chimeric Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human-mouse Chimeric Antibody Breakdown Data by Type
4.1 Global Human-mouse Chimeric Antibody Historic Market Size by Type (2020-2025)
4.2 Global Human-mouse Chimeric Antibody Forecasted Market Size by Type (2026-2031)
5 Human-mouse Chimeric Antibody Breakdown Data by Application
5.1 Global Human-mouse Chimeric Antibody Historic Market Size by Application (2020-2025)
5.2 Global Human-mouse Chimeric Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human-mouse Chimeric Antibody Market Size (2020-2031)
6.2 North America Human-mouse Chimeric Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human-mouse Chimeric Antibody Market Size by Country (2020-2025)
6.4 North America Human-mouse Chimeric Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human-mouse Chimeric Antibody Market Size (2020-2031)
7.2 Europe Human-mouse Chimeric Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human-mouse Chimeric Antibody Market Size by Country (2020-2025)
7.4 Europe Human-mouse Chimeric Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Human-mouse Chimeric Antibody Market Size (2020-2031)
8.2 Asia-Pacific Human-mouse Chimeric Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human-mouse Chimeric Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Human-mouse Chimeric Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Human-mouse Chimeric Antibody Market Size (2020-2031)
9.2 Latin America Human-mouse Chimeric Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human-mouse Chimeric Antibody Market Size by Country (2020-2025)
9.4 Latin America Human-mouse Chimeric Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human-mouse Chimeric Antibody Market Size (2020-2031)
10.2 Middle East & Africa Human-mouse Chimeric Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human-mouse Chimeric Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Human-mouse Chimeric Antibody Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche AG
11.1.1 Roche AG Company Details
11.1.2 Roche AG Business Overview
11.1.3 Roche AG Human-mouse Chimeric Antibody Introduction
11.1.4 Roche AG Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.1.5 Roche AG Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Human-mouse Chimeric Antibody Introduction
11.2.4 Johnson & Johnson Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Celltrion
11.3.1 Celltrion Company Details
11.3.2 Celltrion Business Overview
11.3.3 Celltrion Human-mouse Chimeric Antibody Introduction
11.3.4 Celltrion Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.3.5 Celltrion Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Human-mouse Chimeric Antibody Introduction
11.4.4 Pfizer Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Details
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Human-mouse Chimeric Antibody Introduction
11.5.4 Merck KGaA Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.5.5 Merck KGaA Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Human-mouse Chimeric Antibody Introduction
11.6.4 Sanofi Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Human-mouse Chimeric Antibody Introduction
11.7.4 Teva Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.7.5 Teva Recent Development
11.8 Eli Lilly & Co
11.8.1 Eli Lilly & Co Company Details
11.8.2 Eli Lilly & Co Business Overview
11.8.3 Eli Lilly & Co Human-mouse Chimeric Antibody Introduction
11.8.4 Eli Lilly & Co Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.8.5 Eli Lilly & Co Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Human-mouse Chimeric Antibody Introduction
11.9.4 Amgen Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.9.5 Amgen Recent Development
11.10 Merck & Co
11.10.1 Merck & Co Company Details
11.10.2 Merck & Co Business Overview
11.10.3 Merck & Co Human-mouse Chimeric Antibody Introduction
11.10.4 Merck & Co Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.10.5 Merck & Co Recent Development
11.11 Sandoz
11.11.1 Sandoz Company Details
11.11.2 Sandoz Business Overview
11.11.3 Sandoz Human-mouse Chimeric Antibody Introduction
11.11.4 Sandoz Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.11.5 Sandoz Recent Development
11.12 Shanghai Henlius Biopharmaceutical
11.12.1 Shanghai Henlius Biopharmaceutical Company Details
11.12.2 Shanghai Henlius Biopharmaceutical Business Overview
11.12.3 Shanghai Henlius Biopharmaceutical Human-mouse Chimeric Antibody Introduction
11.12.4 Shanghai Henlius Biopharmaceutical Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.12.5 Shanghai Henlius Biopharmaceutical Recent Development
11.13 United Therapeutics
11.13.1 United Therapeutics Company Details
11.13.2 United Therapeutics Business Overview
11.13.3 United Therapeutics Human-mouse Chimeric Antibody Introduction
11.13.4 United Therapeutics Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.13.5 United Therapeutics Recent Development
11.14 Innovent Bio
11.14.1 Innovent Bio Company Details
11.14.2 Innovent Bio Business Overview
11.14.3 Innovent Bio Human-mouse Chimeric Antibody Introduction
11.14.4 Innovent Bio Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.14.5 Innovent Bio Recent Development
11.15 Mitsubishi Tanabe Pharma
11.15.1 Mitsubishi Tanabe Pharma Company Details
11.15.2 Mitsubishi Tanabe Pharma Business Overview
11.15.3 Mitsubishi Tanabe Pharma Human-mouse Chimeric Antibody Introduction
11.15.4 Mitsubishi Tanabe Pharma Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.15.5 Mitsubishi Tanabe Pharma Recent Development
11.16 Kyowa Kirin
11.16.1 Kyowa Kirin Company Details
11.16.2 Kyowa Kirin Business Overview
11.16.3 Kyowa Kirin Human-mouse Chimeric Antibody Introduction
11.16.4 Kyowa Kirin Revenue in Human-mouse Chimeric Antibody Business (2020-2025)
11.16.5 Kyowa Kirin Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Human-mouse Chimeric Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Infliximab
Table 3. Key Players of Rituximab
Table 4. Key Players of Emicizumab
Table 5. Key Players of Cetuximab
Table 6. Key Players of Esatuximab
Table 7. Key Players of Other
Table 8. Global Human-mouse Chimeric Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Human-mouse Chimeric Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Human-mouse Chimeric Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Human-mouse Chimeric Antibody Market Share by Region (2020-2025)
Table 12. Global Human-mouse Chimeric Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Human-mouse Chimeric Antibody Market Share by Region (2026-2031)
Table 14. Human-mouse Chimeric Antibody Market Trends
Table 15. Human-mouse Chimeric Antibody Market Drivers
Table 16. Human-mouse Chimeric Antibody Market Challenges
Table 17. Human-mouse Chimeric Antibody Market Restraints
Table 18. Global Human-mouse Chimeric Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Human-mouse Chimeric Antibody Market Share by Players (2020-2025)
Table 20. Global Top Human-mouse Chimeric Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human-mouse Chimeric Antibody as of 2024)
Table 21. Ranking of Global Top Human-mouse Chimeric Antibody Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Human-mouse Chimeric Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Human-mouse Chimeric Antibody, Headquarters and Area Served
Table 24. Global Key Players of Human-mouse Chimeric Antibody, Product and Application
Table 25. Global Key Players of Human-mouse Chimeric Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human-mouse Chimeric Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Human-mouse Chimeric Antibody Revenue Market Share by Type (2020-2025)
Table 29. Global Human-mouse Chimeric Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Human-mouse Chimeric Antibody Revenue Market Share by Type (2026-2031)
Table 31. Global Human-mouse Chimeric Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Human-mouse Chimeric Antibody Revenue Market Share by Application (2020-2025)
Table 33. Global Human-mouse Chimeric Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Human-mouse Chimeric Antibody Revenue Market Share by Application (2026-2031)
Table 35. North America Human-mouse Chimeric Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Human-mouse Chimeric Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Human-mouse Chimeric Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Human-mouse Chimeric Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Human-mouse Chimeric Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Human-mouse Chimeric Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Human-mouse Chimeric Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Human-mouse Chimeric Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Human-mouse Chimeric Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Human-mouse Chimeric Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Human-mouse Chimeric Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Human-mouse Chimeric Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Human-mouse Chimeric Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Human-mouse Chimeric Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Human-mouse Chimeric Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 50. Roche AG Company Details
Table 51. Roche AG Business Overview
Table 52. Roche AG Human-mouse Chimeric Antibody Product
Table 53. Roche AG Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 54. Roche AG Recent Development
Table 55. Johnson & Johnson Company Details
Table 56. Johnson & Johnson Business Overview
Table 57. Johnson & Johnson Human-mouse Chimeric Antibody Product
Table 58. Johnson & Johnson Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 59. Johnson & Johnson Recent Development
Table 60. Celltrion Company Details
Table 61. Celltrion Business Overview
Table 62. Celltrion Human-mouse Chimeric Antibody Product
Table 63. Celltrion Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 64. Celltrion Recent Development
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Human-mouse Chimeric Antibody Product
Table 68. Pfizer Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Merck KGaA Company Details
Table 71. Merck KGaA Business Overview
Table 72. Merck KGaA Human-mouse Chimeric Antibody Product
Table 73. Merck KGaA Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 74. Merck KGaA Recent Development
Table 75. Sanofi Company Details
Table 76. Sanofi Business Overview
Table 77. Sanofi Human-mouse Chimeric Antibody Product
Table 78. Sanofi Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 79. Sanofi Recent Development
Table 80. Teva Company Details
Table 81. Teva Business Overview
Table 82. Teva Human-mouse Chimeric Antibody Product
Table 83. Teva Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 84. Teva Recent Development
Table 85. Eli Lilly & Co Company Details
Table 86. Eli Lilly & Co Business Overview
Table 87. Eli Lilly & Co Human-mouse Chimeric Antibody Product
Table 88. Eli Lilly & Co Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 89. Eli Lilly & Co Recent Development
Table 90. Amgen Company Details
Table 91. Amgen Business Overview
Table 92. Amgen Human-mouse Chimeric Antibody Product
Table 93. Amgen Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 94. Amgen Recent Development
Table 95. Merck & Co Company Details
Table 96. Merck & Co Business Overview
Table 97. Merck & Co Human-mouse Chimeric Antibody Product
Table 98. Merck & Co Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 99. Merck & Co Recent Development
Table 100. Sandoz Company Details
Table 101. Sandoz Business Overview
Table 102. Sandoz Human-mouse Chimeric Antibody Product
Table 103. Sandoz Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 104. Sandoz Recent Development
Table 105. Shanghai Henlius Biopharmaceutical Company Details
Table 106. Shanghai Henlius Biopharmaceutical Business Overview
Table 107. Shanghai Henlius Biopharmaceutical Human-mouse Chimeric Antibody Product
Table 108. Shanghai Henlius Biopharmaceutical Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 109. Shanghai Henlius Biopharmaceutical Recent Development
Table 110. United Therapeutics Company Details
Table 111. United Therapeutics Business Overview
Table 112. United Therapeutics Human-mouse Chimeric Antibody Product
Table 113. United Therapeutics Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 114. United Therapeutics Recent Development
Table 115. Innovent Bio Company Details
Table 116. Innovent Bio Business Overview
Table 117. Innovent Bio Human-mouse Chimeric Antibody Product
Table 118. Innovent Bio Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 119. Innovent Bio Recent Development
Table 120. Mitsubishi Tanabe Pharma Company Details
Table 121. Mitsubishi Tanabe Pharma Business Overview
Table 122. Mitsubishi Tanabe Pharma Human-mouse Chimeric Antibody Product
Table 123. Mitsubishi Tanabe Pharma Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 124. Mitsubishi Tanabe Pharma Recent Development
Table 125. Kyowa Kirin Company Details
Table 126. Kyowa Kirin Business Overview
Table 127. Kyowa Kirin Human-mouse Chimeric Antibody Product
Table 128. Kyowa Kirin Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 129. Kyowa Kirin Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Authors List of This Report
List of Figures
Figure 1. Human-mouse Chimeric Antibody Picture
Figure 2. Global Human-mouse Chimeric Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human-mouse Chimeric Antibody Market Share by Type: 2024 VS 2031
Figure 4. Infliximab Features
Figure 5. Rituximab Features
Figure 6. Emicizumab Features
Figure 7. Cetuximab Features
Figure 8. Esatuximab Features
Figure 9. Other Features
Figure 10. Global Human-mouse Chimeric Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Human-mouse Chimeric Antibody Market Share by Application: 2024 VS 2031
Figure 12. Cancers Case Studies
Figure 13. Autoimmune Diseases Case Studies
Figure 14. Transplant Rejection Case Studies
Figure 15. Human-mouse Chimeric Antibody Report Years Considered
Figure 16. Global Human-mouse Chimeric Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Human-mouse Chimeric Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Human-mouse Chimeric Antibody Market Share by Region: 2024 VS 2031
Figure 19. Global Human-mouse Chimeric Antibody Market Share by Players in 2024
Figure 20. Global Human-mouse Chimeric Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Human-mouse Chimeric Antibody Revenue in 2024
Figure 22. North America Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Human-mouse Chimeric Antibody Market Share by Country (2020-2031)
Figure 24. United States Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Human-mouse Chimeric Antibody Market Share by Country (2020-2031)
Figure 28. Germany Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Ireland Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Human-mouse Chimeric Antibody Market Share by Region (2020-2031)
Figure 36. China Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia & New Zealand Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Human-mouse Chimeric Antibody Market Share by Country (2020-2031)
Figure 44. Mexico Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Human-mouse Chimeric Antibody Market Share by Country (2020-2031)
Figure 48. Israel Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Roche AG Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 52. Johnson & Johnson Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 53. Celltrion Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 54. Pfizer Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 55. Merck KGaA Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 56. Sanofi Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 57. Teva Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 58. Eli Lilly & Co Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 59. Amgen Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 60. Merck & Co Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 61. Sandoz Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 62. Shanghai Henlius Biopharmaceutical Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 63. United Therapeutics Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 64. Innovent Bio Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 65. Mitsubishi Tanabe Pharma Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 66. Kyowa Kirin Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Human-mouse Chimeric Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Infliximab
Table 3. Key Players of Rituximab
Table 4. Key Players of Emicizumab
Table 5. Key Players of Cetuximab
Table 6. Key Players of Esatuximab
Table 7. Key Players of Other
Table 8. Global Human-mouse Chimeric Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Human-mouse Chimeric Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Human-mouse Chimeric Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Human-mouse Chimeric Antibody Market Share by Region (2020-2025)
Table 12. Global Human-mouse Chimeric Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Human-mouse Chimeric Antibody Market Share by Region (2026-2031)
Table 14. Human-mouse Chimeric Antibody Market Trends
Table 15. Human-mouse Chimeric Antibody Market Drivers
Table 16. Human-mouse Chimeric Antibody Market Challenges
Table 17. Human-mouse Chimeric Antibody Market Restraints
Table 18. Global Human-mouse Chimeric Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Human-mouse Chimeric Antibody Market Share by Players (2020-2025)
Table 20. Global Top Human-mouse Chimeric Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human-mouse Chimeric Antibody as of 2024)
Table 21. Ranking of Global Top Human-mouse Chimeric Antibody Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Human-mouse Chimeric Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Human-mouse Chimeric Antibody, Headquarters and Area Served
Table 24. Global Key Players of Human-mouse Chimeric Antibody, Product and Application
Table 25. Global Key Players of Human-mouse Chimeric Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human-mouse Chimeric Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Human-mouse Chimeric Antibody Revenue Market Share by Type (2020-2025)
Table 29. Global Human-mouse Chimeric Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Human-mouse Chimeric Antibody Revenue Market Share by Type (2026-2031)
Table 31. Global Human-mouse Chimeric Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Human-mouse Chimeric Antibody Revenue Market Share by Application (2020-2025)
Table 33. Global Human-mouse Chimeric Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Human-mouse Chimeric Antibody Revenue Market Share by Application (2026-2031)
Table 35. North America Human-mouse Chimeric Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Human-mouse Chimeric Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Human-mouse Chimeric Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Human-mouse Chimeric Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Human-mouse Chimeric Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Human-mouse Chimeric Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Human-mouse Chimeric Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Human-mouse Chimeric Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Human-mouse Chimeric Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Human-mouse Chimeric Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Human-mouse Chimeric Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Human-mouse Chimeric Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Human-mouse Chimeric Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Human-mouse Chimeric Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Human-mouse Chimeric Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 50. Roche AG Company Details
Table 51. Roche AG Business Overview
Table 52. Roche AG Human-mouse Chimeric Antibody Product
Table 53. Roche AG Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 54. Roche AG Recent Development
Table 55. Johnson & Johnson Company Details
Table 56. Johnson & Johnson Business Overview
Table 57. Johnson & Johnson Human-mouse Chimeric Antibody Product
Table 58. Johnson & Johnson Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 59. Johnson & Johnson Recent Development
Table 60. Celltrion Company Details
Table 61. Celltrion Business Overview
Table 62. Celltrion Human-mouse Chimeric Antibody Product
Table 63. Celltrion Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 64. Celltrion Recent Development
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Human-mouse Chimeric Antibody Product
Table 68. Pfizer Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Merck KGaA Company Details
Table 71. Merck KGaA Business Overview
Table 72. Merck KGaA Human-mouse Chimeric Antibody Product
Table 73. Merck KGaA Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 74. Merck KGaA Recent Development
Table 75. Sanofi Company Details
Table 76. Sanofi Business Overview
Table 77. Sanofi Human-mouse Chimeric Antibody Product
Table 78. Sanofi Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 79. Sanofi Recent Development
Table 80. Teva Company Details
Table 81. Teva Business Overview
Table 82. Teva Human-mouse Chimeric Antibody Product
Table 83. Teva Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 84. Teva Recent Development
Table 85. Eli Lilly & Co Company Details
Table 86. Eli Lilly & Co Business Overview
Table 87. Eli Lilly & Co Human-mouse Chimeric Antibody Product
Table 88. Eli Lilly & Co Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 89. Eli Lilly & Co Recent Development
Table 90. Amgen Company Details
Table 91. Amgen Business Overview
Table 92. Amgen Human-mouse Chimeric Antibody Product
Table 93. Amgen Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 94. Amgen Recent Development
Table 95. Merck & Co Company Details
Table 96. Merck & Co Business Overview
Table 97. Merck & Co Human-mouse Chimeric Antibody Product
Table 98. Merck & Co Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 99. Merck & Co Recent Development
Table 100. Sandoz Company Details
Table 101. Sandoz Business Overview
Table 102. Sandoz Human-mouse Chimeric Antibody Product
Table 103. Sandoz Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 104. Sandoz Recent Development
Table 105. Shanghai Henlius Biopharmaceutical Company Details
Table 106. Shanghai Henlius Biopharmaceutical Business Overview
Table 107. Shanghai Henlius Biopharmaceutical Human-mouse Chimeric Antibody Product
Table 108. Shanghai Henlius Biopharmaceutical Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 109. Shanghai Henlius Biopharmaceutical Recent Development
Table 110. United Therapeutics Company Details
Table 111. United Therapeutics Business Overview
Table 112. United Therapeutics Human-mouse Chimeric Antibody Product
Table 113. United Therapeutics Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 114. United Therapeutics Recent Development
Table 115. Innovent Bio Company Details
Table 116. Innovent Bio Business Overview
Table 117. Innovent Bio Human-mouse Chimeric Antibody Product
Table 118. Innovent Bio Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 119. Innovent Bio Recent Development
Table 120. Mitsubishi Tanabe Pharma Company Details
Table 121. Mitsubishi Tanabe Pharma Business Overview
Table 122. Mitsubishi Tanabe Pharma Human-mouse Chimeric Antibody Product
Table 123. Mitsubishi Tanabe Pharma Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 124. Mitsubishi Tanabe Pharma Recent Development
Table 125. Kyowa Kirin Company Details
Table 126. Kyowa Kirin Business Overview
Table 127. Kyowa Kirin Human-mouse Chimeric Antibody Product
Table 128. Kyowa Kirin Revenue in Human-mouse Chimeric Antibody Business (2020-2025) & (US$ Million)
Table 129. Kyowa Kirin Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Authors List of This Report
List of Figures
Figure 1. Human-mouse Chimeric Antibody Picture
Figure 2. Global Human-mouse Chimeric Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human-mouse Chimeric Antibody Market Share by Type: 2024 VS 2031
Figure 4. Infliximab Features
Figure 5. Rituximab Features
Figure 6. Emicizumab Features
Figure 7. Cetuximab Features
Figure 8. Esatuximab Features
Figure 9. Other Features
Figure 10. Global Human-mouse Chimeric Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Human-mouse Chimeric Antibody Market Share by Application: 2024 VS 2031
Figure 12. Cancers Case Studies
Figure 13. Autoimmune Diseases Case Studies
Figure 14. Transplant Rejection Case Studies
Figure 15. Human-mouse Chimeric Antibody Report Years Considered
Figure 16. Global Human-mouse Chimeric Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Human-mouse Chimeric Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Human-mouse Chimeric Antibody Market Share by Region: 2024 VS 2031
Figure 19. Global Human-mouse Chimeric Antibody Market Share by Players in 2024
Figure 20. Global Human-mouse Chimeric Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Human-mouse Chimeric Antibody Revenue in 2024
Figure 22. North America Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Human-mouse Chimeric Antibody Market Share by Country (2020-2031)
Figure 24. United States Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Human-mouse Chimeric Antibody Market Share by Country (2020-2031)
Figure 28. Germany Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Ireland Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Human-mouse Chimeric Antibody Market Share by Region (2020-2031)
Figure 36. China Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia & New Zealand Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Human-mouse Chimeric Antibody Market Share by Country (2020-2031)
Figure 44. Mexico Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Human-mouse Chimeric Antibody Market Share by Country (2020-2031)
Figure 48. Israel Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Human-mouse Chimeric Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Roche AG Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 52. Johnson & Johnson Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 53. Celltrion Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 54. Pfizer Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 55. Merck KGaA Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 56. Sanofi Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 57. Teva Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 58. Eli Lilly & Co Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 59. Amgen Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 60. Merck & Co Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 61. Sandoz Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 62. Shanghai Henlius Biopharmaceutical Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 63. United Therapeutics Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 64. Innovent Bio Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 65. Mitsubishi Tanabe Pharma Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 66. Kyowa Kirin Revenue Growth Rate in Human-mouse Chimeric Antibody Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232